Financials Neurone Studio S.A.

Equities

NRS

PLHCKLG00010

Software

End-of-day quote Warsaw S.E. 23:00:00 18/06/2024 BST 5-day change 1st Jan Change
1.19 PLN 0.00% Intraday chart for Neurone Studio S.A. 0.00% +0.85%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 4.501 1.964 10.61 7.216 6.155 2.59
Enterprise Value (EV) 1 4.543 1.095 10.12 7.005 6.018 2.872
P/E ratio -9.18 x -1 x -28.8 x -66.1 x -18.2 x -4.89 x
Yield - - - - - -
Capitalization / Revenue 319 x 1,020 x - 34.4 x 24,620 x -
EV / Revenue 322 x 568 x - 33.4 x 24,073 x -
EV / EBITDA -20.2 x -3.01 x -27.7 x -65.4 x -14.7 x -5.56 x
EV / FCF -14 x 0.42 x -5.8 x -29.3 x 796 x -6.64 x
FCF Yield -7.13% 240% -17.2% -3.41% 0.13% -15.1%
Price to Book 3.23 x -3.43 x 19 x 16 x 54.7 x -9.76 x
Nbr of stocks (in thousands) 1,122 1,122 2,122 2,122 2,122 2,195
Reference price 2 4.010 1.750 5.000 3.400 2.900 1.180
Announcement Date 31/05/19 19/06/20 31/05/21 31/05/22 21/03/23 13/06/24
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0141 0.001926 - 0.2097 0.00025 -
EBITDA 1 -0.2244 -0.3631 -0.3651 -0.1071 -0.4083 -0.517
EBIT 1 -0.2396 -0.378 -0.3737 -0.109 -0.4085 -0.5173
Operating Margin -1,697.82% -19,626.95% - -51.96% -163,412.8% -
Earnings before Tax (EBT) 1 -0.4903 -1.966 -0.3685 -0.1091 -0.3379 -0.5298
Net income 1 -0.4903 -1.966 -0.3685 -0.1091 -0.3379 -0.5298
Net margin -3,473.6% -102,071.91% - -52.02% -135,168.8% -
EPS 2 -0.4368 -1.751 -0.1736 -0.0514 -0.1592 -0.2413
Free Cash Flow 1 -0.3239 2.631 -1.744 -0.2389 0.007565 -0.4324
FCF margin -2,294.94% 136,610.64% - -113.92% 3,026% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 31/05/19 19/06/20 31/05/21 31/05/22 21/03/23 13/06/24
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.04 - - - - 0.28
Net Cash position 1 - 0.87 0.49 0.21 0.14 -
Leverage (Debt/EBITDA) -0.1866 x - - - - -0.5459 x
Free Cash Flow 1 -0.32 2.63 -1.74 -0.24 0.01 -0.43
ROE (net income / shareholders' equity) -29.9% -478% 5,948% -21.6% -120% 694%
ROA (Net income/ Total Assets) -7.99% -17.9% -28.7% -12.4% -64.6% -137%
Assets 1 6.135 11.01 1.283 0.8792 0.5232 0.3874
Book Value Per Share 2 1.240 -0.5100 0.2600 0.2100 0.0500 -0.1200
Cash Flow per Share 2 0.0200 0.0400 0.0200 0.0100 0.0600 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 31/05/19 19/06/20 31/05/21 31/05/22 21/03/23 13/06/24
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NRS Stock
  4. Financials Neurone Studio S.A.